← Open Payments lookup

RYAN COMMISKEY: Open Payments

NPI 1922510577 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,596 in 199 payments from 50 companies in 2025. Trend: 2023 $4,096 · 2024 $4,806 · 2025 $4,596

Food & beverage: $3,798Long term medical supply or device loan: $798
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation31$1,234
Janssen Biotech, Inc.13$256
ABBVIE INC.7$204
AstraZeneca Pharmaceuticals LP12$201
Daiichi Sankyo Inc.8$201
Celgene Corporation17$193
Merck Sharp & Dohme LLC9$174
E.R. Squibb & Sons, L.L.C.10$159
GENZYME CORPORATION5$123
Takeda Pharmaceuticals U.S.A., Inc.3$109

Products named: KISQALI, ENHERTU, KEYTRUDA, REBLOZYL, PLUVICTO, SARCLISA, VENCLEXTA, Orserdu.

Industry payments across NM — which companies pay providers there.